Phase III Study of Tomudex [raltitrexed] and Cisplatin Versus Cisplatin in Malignant Pleural Mesothelioma.

Trial Profile

Phase III Study of Tomudex [raltitrexed] and Cisplatin Versus Cisplatin in Malignant Pleural Mesothelioma.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Oct 2010

At a glance

  • Drugs Cisplatin; Raltitrexed
  • Indications Mesothelioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jan 2010 Actual end date (3 Jan 2003) added as reported from National Cancer Institute of Canada record.
    • 28 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top